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1 Abstract 
Complex regional pain syndrome (CRPS) is a chronic pain disease characterized by 
autonomic changes and usually develops in an extremity after tissue trauma. CRPS 1 
is traditionally defined by the absence of a specific nerve injury. However, recently, a 
minimal nerve injury has been proposed to play a pathophysiologic important role in 
CRPS 1. We combined a closed soft tissue trauma and a minimal nerve injury to 
establish a new animal model in rats, in order to study the effects of tissue trauma 
and minimal nerve injury on the emergence of CRPS-like symptoms.  
The closed soft tissue trauma was induced in the hindlimbs of Sprague Dawley rats 
with a pneumatic impactor. Additionally, the ipsilateral sciatic nerves were crushed 
with an instrumented clamp to cause a minimal nerve injury (30 Newton, 20s). The 
experiment was performed on a total of 42 rats. The rats which received closed soft 
tissue trauma and minimal nerve injury served as the clamp group (N=21). The other 
set of animals with closed soft tissue trauma and sham operation of the nerve served 
as the sham group (N=21). Pain behavior observations and assessment of autonomic 
changes (paw temperature and paw volume) were performed on day 0, 2, 4, 7, 14, 21 
and 28. In vivo fluorescence microscopy was performed in the traumatized muscle on 
day 2, 7 and 28 in order to assess the regional inflammation and tissue perfusion. 
Nerve conduction was applied in the operated sciatic nerve to assess its conductive 
function. Additionally, muscle cell apoptosis in the traumatized muscle was assessed 
by both in vivo fluorescence microscopy and caspase-3 immunohistochemistry.  
As a result, shortly after the surgery the clamp group with closed soft tissue trauma 
and minimal nerve injury developed pronounced signs of neuropathic pain 
(spontaneous pain, hot and cold allodynia and mechanical hyperalgesia), while the 
sham group remained pain free. Besides the neuropathic pain, increased temperature, 
edema formation, regional inflammation, tissue perfusion failure, tissue hypoxia and 
enhanced muscle cell apoptosis appeared in both the clamp and the sham group. 
However, most symptoms of neuropathic pain in the clamp group and muscle cell 
apoptosis in both groups vanished within the 28 days of observation. The autonomic 
changes, regional inflammation and microcirculatory deterioration disappeared in 
both groups at 7 day.  
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CRPS-like symptoms were detected in our animal model. The minimal nerve injury led 
to a pronounced neuropathic pain. The closed soft tissue trauma induced 
posttraumatic sequelae, such as regional inflammation, circulatory deterioration and 
muscle cell apoptosis. However, most of the symptoms were transient and 
completely disappeared within 28 days. Thus, the closed soft tissue trauma and 
minimal nerve injury are not sufficient to induce an ongoing CRPS.  
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2 Zusammenfassung 
Das Komplexe Regionale Schmerzsyndrom (CRPS) ist eine Erkrankung, die durch 
Schmerz, sensible, motorische und autonome Veränderungen charakterisiert ist und 
typischerweise nach einem Extremitätentrauma auftritt. Hierbei wird in CRPS 1 ohne 
nachweisbaren und CRPS 2 mit definiertem - Nervenschaden unterschieden. In letzter 
Zeit wurde jedoch auch für das CRPS 1 eine pathophysiologisch bedeutsame minimale 
Nervenverletzung postuliert. Wir kombinierten ein geschlossenes Weichteiltrauma 
mit einer minimalen Nervenverletzung bei der Ratte um an diesem neuen Tiermodell 
das Auftreten CRPS-typischer Symptome zu untersuchen.  
Das geschlossene Weichteiltrauma wurde standardisiert mittels Druckbolzen auf den 
Hinterlauf von Sprague Dawley Ratten appliziert. Zusätzlich erfolgte eine 
Nervenquetschung am ipsilateralen N. ischiadicus (30 Newton für 20s). Tiere, die eine 
Weichteil- und Nervenverletzung erhielten, wurden als “Clamp Gruppe” bezeichnet 
(n=21). Als Kontrolle dienten 21 weitere Tiere, die das Weichteiltrauma erhielten, bei 
denen der N. ischiadicus lediglich dargestellt und nicht weiter traumatisert wurde. 
Das Schmerzverhalten, sowie autonome Veränderungen (Temperaturunterschiede 
und Ö dem der Pfoten) wurden an Tag 0, 2, 4, 7, 14, 21 und 28 gemessen. Um die 
lokale Entzündungsreaktion und Gewebeperfusion zu beurteilen wurde an Tag 2, 7 
und 28 eine in vivo Fluoreszenzmikroskopie des ipsilateralen M. soleus durchgeführt. 
Die Muskelzellapoptose wurde sowohl in vivo fluoreszenzmikroskopisch , als auch 
immunhistochemisch bestimmt. Zur Darstellung der neuronalen Konduktivität führten 
wir eine Messung der Nervenleitlatenz des N. ischiadicus durch. 
Bereits kurz nach der Traumatisierung zeigten alle Tiere der “Clamp Gruppe” ein 
erhebliches neuropathisches Schmerzverhalten (Spontanschmerz, Kälte- und 
Wärmeallodynie und mechanische Hyperalgesie), während die Tiere der 
Kontrollgruppe keinerlei Schmerzverhalten demonstrierten. Neben dem 
neuropathischen Schmerz stellten sich Veränderungen in Pfotentemperatur, 
Muskelödem, regionaler Entzündung im verletzten Muskel, Muskelzellapoptose und 
Gewebeperfusion und -oxygenierung in beiden Versuchsgruppen dar. Die Symptome 
des neuropathischen Schmerzes waren über den Beobachtungszeitraum rückläufig 
und erreichten zum Ende der Untersuchung das Ausgangsniveau. Die autonomen 
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Veränderungen und Parameter der lokalen Entzündung und Mikrozirkulation lagen 
bereits ab dem 7. Tag wieder im Normbereich. 
In diesem neuen Tiermodell konnten wir Symptome des CRPS induzieren. Die 
minimale Nervenverletzung führte zu einer deutlichen neuropathischen 
Schmerzsymptomatik. Die zusätzlich durchgeführte Weichteiltraumatisierung 
erzeugte typische posttraumatische Folgeerscheinungen wie regionale Entzündung, 
Störungen der Mikrozirkulation, und Muskelzellapoptose. Allerdings waren die 
meisten Symptome nur vorübergehend und zum Ende der Untersuchung nicht mehr 
nachweisbar. Die Kombination von Weichteiltrauma und minimaler Nervenverletzung 
waren In diesem Tiermodell nicht geeignet, ein anhaltendes CRPS zu erzeugen. 
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3 Introduction 
3.1 Background 
In the American civil war, an uncommon pain disease was reported by Dr. Silas Weir 
Mitchell. He found that some soldiers with gunshot wounds developed a severe 
painful condition which could not be explained by the initial trauma. The initial 
gunshot wound in the limb led to an intense and persisting pain in the remote 
extremity. The pain was described as burning and the affected patients often refused 
to be examined. Besides the pain, glossy red skin was also reported in some of the 
cases. This pain condition was first considered to be due to nerve trunk irritation. 
Mitchell tried several treatments which included leeches, electrostimulation, massage 
and blistering. However, none of these methods led to satisfying results. Mitchell 
used the term “causalgia” (combination of Greek word “Kausis” and “Algos” which 
mean “hot” and “pain”) to describe the commonly observed burning pain 1, 2. 
In 1900, the posttraumatic pain associated with edema and bone atrophy was 
independently described by Sudeck 3. He proposed an exaggerated inflammatory 
response to trauma or operation being the major cause and coined the term 
“inflammatory bone atrophy” (Sudeck atrophy) 4. 
In the early 20th century, the French surgeon Leriche made detailed reports about 
causalgia in traumatized limbs. He suggested sympathectomy as a therapy, but 
sympathectomy was still not able to resolve the pain condition 5. In 1946, based on 
the observations of Leriche, Evans proposed a theory of sympathetic dysfunction. He 
believed that the development of exaggerated pain was due to the hyperactivity of 
the sympathetic nervous system. In his theory, continuous nociceptive input 
generated by a trauma affects the spinal cord and enhances the output signal of the 
sympathetic nervous system and further leads to symptoms in the affected extremity. 
The term “Reflex Sympathetic Dystrophy (RSD)“ was put into use in order to reflect 
the assumed sympathetic pathophysiology 6. 
Later on, many terms based on the clinical features, evidence of nerve lesion, trophic 
changes, responses to treatment and different theories emerged due to poor 
understanding of pathogenic reasons. This diversity of terms also led to confusion, 
misdiagnosis and mistreatment of this pain disease 3. In this situation, a more 
accurate and widely accepted nomenclature was in sore need. In 1993, the 
International Association for the Study of Pain (IASP) reviewed the nomenclature and 
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developed a set of diagnostic criteria. In 1994, by the common consent of 
participating scholars, the term Complex Regional Pain Syndrome (CRPS) was 
announced 7. 
3.2 Definition 
Complex Regional Pain Syndrome (CRPS) is a chronic pain disease distinguished by 
neuropathic pain, sensory disturbance, temperature alteration, edema, sudomotor 
and trophic changes. 
Based on the presence of nerve injury, CRPS can be subdivided into two types, CRPS 1 
and CRPS 2. 
CRPS 1 develops after trauma without specific nerve injury and was formerly known 
as reflex sympathetic dystrophy (RSD) or Sudeck atrophy. 
CRPS 2 develops after trauma combined with verified nerve injury and was formerly 
termed causalgia. 
3.3 Epidemiology and prognosis 
CRPS usually develops after acute tissue trauma or operation. A study in the United 
States showed an incidence of 5.5/100,000 person per year 8. Another higher 
incidence (26.2/100,000) was reported in the Netherlands. CRPS develops more often 
in the upper limbs. More females than males are affected, with a ratio of approximal 
3:1. Advanced age is another risk for CRPS 9. Fracture is the most common initial 
event, followed by surgery, crush injury, sprain and even minimal injury 10. Distal 
radius fracture is the most common cause of CRPS 1. The incidence has been 
described to be between 8% to 39% 11-13.  
In a prognostic study of CRPS, 6 years after the onset, 30% of the patients had 
recovered and 54% were considered as stable. However, 16% of the patients reported 
severe progressive symptoms. Of the 54% patients with a stable condition, 41% could 
resume their former job completely, 28% could resume work with an adjusted 
occupation or reduced working hours. The other 31% were not able to work anymore 
14. The outcome of CRPS seems to be grim, less than 1/3 of the patients recovered, a 
large proportion of the rest lost their work ability, some patients still need long-term 
treatment (pharmacologic, invasive treatment, or physiotherapy) 14. In 1998, the 
average cost for the health-care (excluding physiotherapy) of a CRPS patient was € 
5700/year in the Netherlands 15. The resulting high unemployment and expensive 
treatment put a heavy socioeconomic burden to both patients and the state.  
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3.4 Diagnosis and clinical presentation of CRPS 
Early recognition and prompt treatment can improve the outcome of CRPS 16. 
However, the early signs of CRPS are often unspecific. Pain, numbness, swelling, and 
stiffness are also normal symptoms seen after trauma or operation, which leads to 
misinterpretation and misdiagnosis 12. The lack of distinct early signs and effective 
diagnostic tools usually contributes to a delayed diagnosis. The diagnosis of CRPS is 
based primarily upon the anamnesis and symptoms elicited during physical 
examination. The IASP diagnostic criteria were published in 1994. These diagnostic 
criteria have a high sensitivity (0.99) but unsatisfying specificity (0.41), leading to 
over-diagnosis 3. The Budapest diagnostic criteria (2003) (Tab. 1) were published with 
an improved specificity (0.68). A subset of Budapest criteria were developed with a 
higher specificity (0.79) for research purpose 17. 
 
Tab. 1. Budapest clinical diagnostic criteria for CRPS 17 
1. Continuing pain, which is disproportionate to any inciting event. 
2. Must report at least one symptom in three of the four following categories: 
• 
• 
 
• 
 
• 
Sensory: hyperalgesia and/or allodynia 
Vasomotor: temperature asymmetry and/or skin color changes and/or 
skin color asymmetry 
Sudomotor/edema: edema and/or sweating changes and/or sweating  
asymmetry 
Motor/trophic: decreased range of motion and/or motor dysfunction 
(weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin) 
3. Must display at least one sign at time of evaluation in two or more of the 
following categories: 
• 
 
• 
 
• 
 
• 
Sensory: hyperalgesia (to pinprick) and/or allodynia (to light touch 
and/or deep somatic pressure and/or joint movement) 
Vasomotor: temperature asymmetry and/or skin color changes and/or  
asymmetry 
Sudomotor/edema: edema and/or sweating changes and/or sweating  
asymmetry 
Motor/trophic: decreased range of motion and/or motor dysfunction  
(weakness, tremor, dystonia) and/or trophic changes (hair, nail, skin) 
4. There is no other diagnosis that better explains the signs and symptoms. 
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3.4.1 Pain 
Continuing pain, which is out of proportion to the initial trauma, is the main feature 
of CRPS. The pain usually manifests near the site of injury, it can spread to the whole 
limb and even to the opposite side 18. The spontaneous pain is usually described as 
burning or shooting pain and can be heightened by emotional or physical stress. The 
intensity and duration of pain can vary from case to case and the symptoms can get 
worse over time 14.  
3.4.2 Sensory disturbance 
Sensory disturbance, especially the exaggerated evoked pain is another key feature of 
CRPS. Exaggerated evoked pain includes allodynia and hyperalgesia 19. The term 
allodynia refers to pain experienced upon innocuous stimulation, like a slight touch or 
even the air flow in the affected region. Hyperalgesia describes a hypersensitivity to 
noxious stimuli that are slightly painful under normal conditions. 
3.4.3 Vasomotor dysfuntion 
Vasomotor dysfunction includes altered skin temperature and/or color. In most cases 
of CRPS, the affected extremities are abnormally warm, usually 1˚C warmer 20. The 
warm skin can become unusually cold over time 21. However, about 30% patients 
experience cold CRPS from the beginning with decreased temperature in their 
affected limbs 22.  
3.4.4 Sudomotor dysfuntion and edema 
Patients with CRPS often show altered sweating, especially in CRPS 1. Hyperhidrosis is 
more common than hypohidrosis 23. Edema is quite common in CRPS affected limb, it 
is usually observed in the early stage and diminishes over time 24. 
3.4.5 Motor and trophic changes 
Motor and trophic changes are frequently observed in CRPS. Most of the patients 
report motor function disturbances, which include motor weakness, tremor and 
dystonia 20, 25. Abnormal hair and nail growth can happen in the affected area. In the 
chronic stage, atrophy of muscle and skin as well as contractures can appear 24. Pain, 
edema formation and consequent contractures can severely limit the range of motion 
of CRPS affected limbs.  
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3.5. Treatment and therapy 
Due to the puzzling nature of the disease and lack of pathophysiologic understanding, 
the therapy for CRPS is an unresolved issue. The current treatment for CRPS is mainly 
aiming on symptom control and rehabilitation therapy. 
3.5.1 Physical therapy 
Physical therapy is the most frequently applied method. Common methods include 
transcutaneous electrical nerve stimulation, progressive weight bearing, tactile 
desensitization, massage and contrast bath therapy 26. Physical therapy is proven to 
reduce pain, improve the motor function and abate trophic changes such as 
contracture and vascular compromise in the late stage 26. Physical therapy should be 
applied below the pain threshold, since the symptoms can be exaggerated by a 
painful stimulation 27, 28. 
3.5.2 Pharmacotherapy 
Current pharmacotherapy for CRPS is mostly symptomatic treatment. According to 
the therapeutic guideline of Association of the Scientific Medical Societies in Germany 
(AWMF), analgesics, bisphosphonates, calcitonin, free radical scavengers and 
corticosteroids can be considered for treating CRPS. Opioids are usually applied in the 
acute stage of intense pain, but they are thought to be less effective for treating 
chronic pain 29. Sodium channel blockers were found to reduce spontaneous pain and 
specific characteristics of evoked pain 30. The administration of antidepressants can 
alleviate neuropathic pain and manage the comorbidities of CRPS, such as depression 
and sleep disorder 31. Gabapentin, which is an anticonvulsant, is also proven to have 
analgesic effects in neuropathic pain and can lead to pain relief in some CRPS cases 32, 
33. However, in a double blind study, the pain score of the gabapentin treated group 
showed no difference compared to the control group 34. Besides the pain 
management, the inflammation-like symptoms such as redness, swelling and heat are 
treated with NSAIDs and corticosteroids. Since neurogenic inflammation is a possible 
mechanism of CRPS, the administration of anti-inflammatory drugs can be promising, 
though more consistent studies are needed to support its effectiveness 35.  
3.5.3 Sympathetic blocks 
Sympathetic blocks can be applied secondarily in some patients with CRPS. The 
patients with sympathetic maintained pain (SMP) are likely to have relief after the 
procedure. However, this method can not help the patients with sympathetic 
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independent pain (SIP). Sympathetic blocks should be applied together with physical 
therapy 36.  
3.5.4 Spinal cord stimulation 
Spinal cord stimulation is an invasive therapeutic method for CRPS. A stimulator can 
be implanted in the epidural space or directly over the nerves located outside the 
central nervous system. The signal generated by the device can stimulate the spinal 
cord directly to control the pain. Besides the stimulator implantation, a drug pump 
can also be implanted to continuously deliver analgesics centrally instead of oral 
administration. Though the spinal cord stimulation is effective, noninvasive methods 
are preferred 37. 
3.6 Pathophysiology 
The pathophysiology of CRPS is still largely unknown. Numerous studies addressing 
the pathophysiology of CRPS have been carried out during the past decades. It has 
become commonly accepted that multiple mechanisms are involved.  
3.6.1 Peripheral sensitization 
A peripheral sensitization can be triggered by the initial trauma of CRPS. After being 
traumatized, the primary afferent nociceptors and Schwann cells of injured nerves 
secrete neuropeptides such as substance P (SP), calcitonin gene related peptide 
(CGRP) and several inflammatory factors (TNF-α, IL-1β and IL-6) 38. Those factors 
activate their receptors expressed on the primary nociceptors and lead to increased 
excitability and decreased firing threshold, which can make an innocuous stimulation 
painful and exaggerate a noxious stimulation 39. At the same time, the continuous 
nociceptive input generated by the peripheral nociceptors may affect the sensory 
neurons in the spinal cord and contribute to a central sensitization. 
3.6.2 Central sensitization 
Central sensitization is an increased excitability of nociceptive neurons in the spinal 
cord or higher nervous centre. Central sensitization is thought to be triggered by 
repeated nociceptive afference 40. The sensory inflow generated by the initial trauma 
is carried into the spinal cord by primary afferent fibers. This nociceptive input leads 
to a central expression of neuropeptides (SP, bradykinin and CGRP) and excitatory 
amino acid glutamate in the spinal cord 41. Those factors act on the relative receptors 
in the nociceptive neurons of the dorsal horn and increase their excitability 42. When 
neurons in the dorsal horn are sensitized, they increase spontaneous activity and 
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decrease the threshold to peripheral stimulation 42. These altered activities turn the 
neurons in the dorsal horn into an amplifier for peripheral nociceptive input and 
finally lead to allodynia and hyperalgesia 41, 43. 
The initial trauma can induce peripheral sensitization. Peripheral sensitization may 
generate continuous nociceptive input and cause a central sensitization. It is likely 
that the peripheral sensitization and central sensitization coincide in CRPS rather than 
happen separately.  
3.6.3 Neurogenic inflammation 
Patients with CRPS frequently develop inflammation-like symptoms such as redness, 
swelling, altered temperature and pain. Some researchers proposed that CRPS is an 
inflammatory disease 44. As we mentioned in the section of peripheral sensitization, 
the primary afferent fibers, especially the C fiber has an efferent neurosecretory 
function. It can release neuropeptides (SP and CGRP) and TNF-α following a nerve 
lesion 45. Several studies found an up-regulation of neuropeptides and TNF-α in CRPS 
affected limbs 46-48. SP induces extravasation of plasma protein and subsequent 
edema formation 45. CGRP is a potent vasodilator which can induce temperature and 
color change 49. TNF-α is a proinflammatory factor which can initiate the secretion of 
inflammatory factors. It can also act on the TNF receptor-1 which is expressed on the 
primary nociceptors to enhance this excitability and lead to pain sensitization 50. At 
the same time, some negative results of neurogenic inflammation were also reported. 
In some studies, the proliferation of immunocytes and regional levels of inflammatory 
factors were assessed in CRPS patients. However, no difference was found between 
CRPS cases and control 51-53. Those negative findings make the proposal of a 
neurogenic inflammation somewhat controversial. Anyhow, a neurogenic 
inflammation may explain the early features of CRPS, but it is also interesting to note 
that the inflammation-like symptoms such as redness, edema and heat are usually 
absent in the chronic stage of CRPS, but the pain can still persist 8. This may imply that 
in the chronic stage, the pain can be independent from the inflammatory processes. 
3.6.4 Sympathetic dysfunction 
Some of the symptoms found in CRPS can be explained by a dysfuntion of the 
sympathetic nervous system (SNS). In the early stage, the sympathetic outflow is 
found to be inhibited in CRPS cases 54. The inhibited sympathetic outflow leads to 
cutaneous vascular vasodilation. As a result, the affected limb can be red and warm, 
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which is a common feature of CRPS. As a compensation of weakened sympathetic 
function, both the density and sensitivity of the adrenoceptors are elevated 35, 55. 
Wasner reported exaggerated vasoconstriction to cold challenge in CRPS affected 
limbs, but the level of circulating norepinephrine was surprisingly low 56. This may 
indicate an excessive sympathetic reaction caused by the compensatory up-regulation 
of the adrenoceptors, even if the outflow of SNS is low. This consequent heightened 
sympathetic vasoconstriction may explain why a warm CRPS can turn into a cold type 
in the chronic stage. Excessive vasoconstriction can impair the local circulation and 
oxygen exchange, and thus leads to tissue hypoxia and acidosis, which can be a 
reason for pain 57. On the other hand, the alpha-adrenoceptors expressed on the 
nociceptive afferents are also up-regulated. Circulating adrenaline can directly 
activate these receptors and contribute to sympatho-afferent coupling, which means 
a persistent pain can be maintained by sympathetic outflow 58, 59. Sympathetic 
dysfunction may be responsible for some of the features of CRPS. However, 
sympathetic blockade can not help most of the patients with CRPS, which suggests 
that other mechanisms are also involved 60. 
3.6.5 Genetic factors 
Genetic factors are assumed to be involved in the development of CRPS. Herlyn et al 
found a significant association between the α1a-adrenoceptor gene and CRPS 1 which 
developed after a radius fracture 11. In another study, Vaneker et al reported the 
association between a promotor polymorphism in the gene of TNF-α and CRPS 1 61. 
However, no single genetic cause can be linked to the occurrence of CRPS so far. 
3.6.6 Minimal nerve injury in CRPS 1 
CRPS 1 is traditionally defined by the absence of a nerve lesion. Recently, the current 
definition of CRPS 1 has been challenged. Oaklander et al related an evidence of 
epidermal neurite loss in the CRPS 1 affected limbs of humans 62, 63. They proposed 
that a minimal nerve injury is involved and CRPS 1 is rather a small fiber neuropathy 64, 
65. The “small fibers” are refer to small-diameter unmyelinated fibers (C fiber) and thin 
myelinated fibers (Aδ fiber), both of which are main primary nociceptive afferent 
fibers 64. Those fibers are easily damaged during a trauma or an operation 65. 
Compared with a nerve trunk lesion, a minimal nerve injury is usually undetectable by 
physical examination or surface nerve conduction 64. This may explain why a minimal 
nerve injury has not been described in CRPS so far. Though the evidence of 
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neuropathy in CRPS 1 was reported, the distinct mechanism how a minimal nerve 
injury could lead to CRPS 1 is still not clear. 
Other factors such as cortical reorganization and psychological factors have also been 
implicated in the pathophysiology of CRPS 66, 67. However, those theories remain in the 
stage of assumption. The mechanism how CRPS occurs and develops is still to be 
further clarified. 
3.7 Animal models 
Patients with CRPS typically develop intense neuropathic pain. The pain can be 
exaggerated by touch or physical examination and lead to a progress of the symptoms 
or even trigger a relapse 27, 28. Because of this, many studies of CRPS are based on 
animal models. In the past decades, several animal models have been established in 
order to study the pathophysiology and symptomatology of CRPS. The common 
animal models are as follows. 
3.7.1 Sciatic nerve chronic constriction injury model (CCI model) 
In 1988, Bennett and Xie developed an animal model of neuropathic pain. In this 
model, the sciatic nerve of a rat was isolated from surrounding tissue, 4 ligatures 
were tied loosely around it in order to produce continuous stimulation 68. CCI led to 
persistent neuropathic pain and trophic changes such as muscle atrophy and 
abnormal claw growth in the animals. This method is easy to perform and 
reproducible, which makes CCI become a classical model to study the neuropathic 
pain and its long-term effect. However, it is limited to modeling CRPS 2 which is 
defined by a specific nerve lesion. 
3.7.2 Tibial fracture model 
Fracture is the most common cause for CRPS 1. A fracture model in rodents was 
established by Guo et al in order to study posttraumatic CRPS 1 69. In this model, a 
tibial fracture was induced with adjusted pliers. Subsequently, the affected hindlimb 
was wrapped in a casting tape for 4 weeks. Another group without fracture was also 
immobilized for control. Tibial fracture and immobilization induced CRPS-like 
symptoms such as allodynia, edema, plasma protein extravasation and periarticular 
osteoporosis. Interestingly, the control group also developed similar symptoms after 
an immobilization for 4 weeks. This finding indicates that a postoperative 
immobilization may prompt the development of CRPS, but at the same time, the 
effect of a tibial fracture in this model becomes unclear. 
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3.7.3 Chronic post-ischemia pain model (CPIP model) 
A novel hypothesis was proposed by Coderre et al in 2004. They speculated that CRPS 
1 is due to deep-tissue ischemia and inflammation. Based on this idea, an ischemia-
reperfusion (I-R) model was established. A tourniquet was placed around the ankle of 
anesthetized rats for 3 hours. Hyperemia, edema and neuropathic pain were 
observed following reperfusion. Evaluation of inflammatory parameters showed 
elevated proinflammatory factors early after the reperfusion 70. Additionally, the I-R 
injury led to signs of sympathetic dysfunction, including up-regulation of α-
adrenoceptors and enhanced sensitivity to catecholamines. Coderre and colleagues 
believe that both CRPS 1 and CRPS 2 are initiated by the same event, a microvascular 
I-R injury that follows a trauma. However, different results appeared in the study of 
Ludwig et al, after a ligation to the femoral artery of rats for 3 hours and subsequent 
reperfusion, no trophic change or pain was observed 71. The finding of Ludwig et al 
does not support the proposal of I-R injury being the major cause of CRPS. Compared 
with the method of femoral artery ligation, a whole limb constriction in the I-R model 
is likely to cause a nerve compression and thus rather CRPS 2.  
3.7.4 Needlestick distal nerve injury model (DNI model) 
Oaklander et al reported a loss of epidermal neurites (29%) in the CRPS 1 affected 
limbs of humans 62. This evidence showed a relationship between neuropathy and 
CRPS 1 which is traditionally defined to be without any nerve lesion. Oaklander et al 
proposed that CRPS 1 is induced by an injury of the small nerve fibers 64. Based on this 
idea, a needlestick distal nerve injury model (DNI) was developed in rats 72. Here a 
penetrating injury of the tibial nerve with needles of 3 different diameters (18G, 22G 
and 30G) was induced. As a result, mechanical hyperalgesia and loss of epidermal 
neurites were detected. Interestingly, only a portion of the animals from the DNI 
group developed these symptoms which are independent on the needle diameter. 
These findings match what we see in the clinic that most of patients with a trauma do 
not develop CRPS. Additionally, this study also reported pain sensitivity and neurites 
loss in the innervating area of uninjured nerves and even in the contralateral limb, 
which can reflect the spread of symptoms in CRPS. However, some of the animals 
with neuropathic pain have already recovered in 14 days, but the pain in patients with 
CRPS is usually more long-lasting. This model has successfully reproduced several 
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features of human CRPS 1, but it is still not able to fully model the progressive 
symptoms of CRPS. 
3.7.5 Exaggerated tissue trauma (ETR model) 
In order to study the pathophysiology of CRPS 1, an animal model of exaggerated 
tissue trauma in rats was developed by Gradl et al 73. In this model, a standardized 
soft tissue trauma was induced in the hindlimbs of rats by a pneumatically driven 
impact device. A supernatant of the traumatized muscular tissue was prepared by 
homogenization and centrifugation. This mediator-enriched supernatant was infused 
to the limbs of rats with a standardized soft tissue trauma in order to induce an 
exaggerated tissue trauma (ETR). Animals which received standardized soft tissue 
trauma (TR), infusion of supernatant of non-traumatized muscle (STR) and untreated 
animals (CO) were included for control. As a result, the ETR group developed a 
temporal mechanical hyperalgesia for 14 days, but no hot or cold allodynia was 
detected, while the other groups were pain-free. The animals with soft tissue trauma 
showed enhanced inflammatory responses in the traumatized muscle, the 
posttraumatic inflammation was found most pronounced in the ETR group. However, 
the method of ETR only induced some temporal CRPS-like symptoms instead of an 
ongoing CRPS. 
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4 Goal in research 
The current animal models are of great help in understanding the pathophysiology 
and symptomatology of CRPS. However, none of them can fully reproduce the 
development of CRPS. The animal model of exaggerated tissue trauma by Gradl et al 
has produced pronounced regional inflammation and CRPS-like symptoms. However, 
it failed to induce ongoing signs of CRPS. At the same time, the current concept of 
CRPS 1 and CRPS 2 being two different entities has been challenged by Oaklander et 
al. They reported the evidence of neuropathy in CRPS 1 which is traditionally defined 
by the absence of a nerve lesion and proposed an injury to small nerve fibers being 
the cause of CRPS 1. Tissue trauma is the most common initializing event of CRPS 1. 
However, it is not clear that whether a minor nerve injury plays an essential role 
besides the trauma. To answer this question, we combined a closed soft tissue 
trauma and an extra minimal nerve injury in order to establish a new model of CRPS. 
Further assessments of pain behavior, autonomic changes, regional inflammatory 
response, microcirculation and cell apoptosis were performed with various 
techniques, in order to clarify the following questions: 
 
• Can a single soft tissue trauma lead to neuropathic pain and other symptoms of 
CRPS? 
• Can a combined injury of closed soft tissue trauma and a minimal nerve injury lead 
to CRPS-like symptoms? 
• Are the combination of closed soft tissue trauma and a minimal nerve injury 
sufficient to induce ongoing symptoms of CRPS? 
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5 Material and Methods 
5.1 Animals 
The experiments were performed in male Sprague Dawley rats (body weight 250-
300g; Charles River Labortaries, Sulzfeld, Germany) which were kept on water and 
standard laboratory chow ad libitum. The experimental protocol was approved by the 
local animal rights protection authorities (LALLF 7221.3-1.2-025/11 (1.1-090/10)) and 
followed the National Institutes of Health guidelines for the care and use of 
laboratory animals. 
5.2. Experimental groups 
42 animals were divided into two groups, the sham group and clamp group (n=21 for 
each group). Based on the duration of experiment, both groups were divided into 3 
subgroups (2 days, 7 days and 28 days group, n=7 for each subgroup). The grouping 
method, experimental duration and interventions are given in Tab. 2. 
Tab. 2. Group information 
 2 days 7 days 28 days interventions 
sham 7 7 7 soft tissue trauma + sham operation 
clamp 7 7 7 soft tissue trauma + minimal nerve injury 
5.3 Surgical procedure 
5.3.1 Closed soft tissue trauma 
Animals were anesthetized with 6% pentobarbital-sodium (55mg/kg body weight i.p, 
Narcoren, Merial, Hallbergmoos, Germany). The left hindlimb was shaved and fixed 
into a plastic mold which fits the shape of the rats’ limb in order to avoid kinetic 
energy loss due to movement (Fig .1). By means of a pneumatically driven impact 
device (custom made by the workshop of the Medical Faculty, University of Rostock, 
Germany), a standardized soft tissue trauma was induced on the lateral tibial 
compartment of the hindlimb, resulting in a high energy and velocity impact trauma 
in the lower extremity 74. 
The pneumatic impact device consists of a compressed nitrogen gas source and an 
adjustable impactor. The parameters of impact were selected to a velocity of 7m/s, a 
deformation depth of 11mm and a contact duration of 100ms. The diameter of the 
impactor is 10mm75, 76. After the tissue trauma, the traumatized limb was carefully 
examined to exclude fracture and skin laceration. The soft tissue trauma was induced 
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in a total of 42 rats.  
  
Fig. 1. Induction of the closed soft tissue trauma. A: The pneumatically driven impact device; B: The left 
hindlimb of a rat was fixed in a plastic mold to be traumatized by the impactor. 
5.3.2 Minimal Nerve Injury 
The animals were placed on a heating plate immediately after the soft tissue trauma 
to keep the body temperature at 37˚C. After preparing and disinfecting the skin, an 
incision of 1cm length was made on the left thigh. The surgical approach was made 
bluntly through the biceps femoris. The left sciatic nerve was exposed at the level of 
the middle of the thigh and carefully separated from adhering tissue by blunt 
dissection 68. The minimal nerve injury was induced with an instrumented clamp 
which was connected to a computer. The force and duration of clamping were 
monitored online. The clamping force of 30 Newton (2xlock of the clamp) and 
duration of 20s were selected since this procedure induces a moderate nerve injury 
without complete nerve damage (several different settings of crush injury were 
tested in the previous trails (data not shown)). The sciatic nerve was placed between 
the two pincers of the clamp, when the monitored clamping force showed a steady 
waved course around the baseline, the pincers were closed with 2 locks and the nerve 
was clamped for 20s (Fig. 2).  
On the other hand, the sciatic nerve of the sham group was only exposed without 
being clamped. After the surgical procedure, animals were placed back to their cages, 
allowed to recover from anesthesia and had free access to food and drinking water. 
5.4 Pain assessment 
To assess the neuropathic pain, spontaneous behavior, pain behaviors to hot, cold 
and mechanical stimuli were observed on different days. The day of surgery was 
defined as day 0, behavior was observed on day 0 prior surgery and served as 
A B 
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baseline. After surgery, observation was carried out on day 2, 4, 7, 14, 21 and 28. For 
the observation, the experimental animals were placed in a transparent plexiglass box 
(22cm x 16cm x 15cm) (custom made by the workshop of the Medical Faculty, 
University of Rostock, Rostock, Germany) which provides good ventilation and perfect 
vision. Different stimulations were applied by changing the bottom plate of the box 
(Fig. 3).  
  
 
Fig. 2. Induction of the minimal nerve injury. A: The instrumented clamp which is connected to a 
computer for monitoring; B: The exposed sciatic nerve (black arrow) and the instrumented clamp 
(white arrow); C: Clamping force and duration were recorded online. 
 
5.4.1 Pain behavior observation 
Spontaneous pain was observed when the animals were placed on an ordinary plastic 
plate under room temperature (21°C). The hot and cold stimulation was applied by 
using a heating (40°C) or a cooling plate (4°C). Before each observation, the animals 
A B 
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were allowed to habituate to the environment for 10min without any intervention 
from the observer. 
  
  
Fig. 3. Pain behavior observation. A: The ordinary plate (21°C); B: The heating plate (40°C); C: The 
cooling plate (4°C); D: The metal mesh plate for mechanical stimulation. 
The observation of each pain type includes 3 trials. Each trial lasted for 300s, a total 
period of 900s for each observation was recorded. The criteria of pain behavior used 
in the experiment are as following: 0=the paw is pressed normally on the floor; 1=the 
paw rests slightly on the floor and the toes are in a ventroflexed position; 2=the paw 
rests slightly on the floor and the external edge is suspended; 3=only the heel is 
pressed on the floor, the paw is in an inverted position; 4=the whole paw is elevated; 
5=the animal licks the operated paw (Fig. 4) .The duration of different positions was 
recorded during the observation. Based on the scale of different positions, a 
quantification of pain behavior was performed and the numerical pain index was 
calculated with the given formula 77:  
0*T0+1*T1+2*T2+3*T3+4*T4+5*T5/900 
B A 
D C 
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T0 to T5 are the durations (s) spent in the corresponding positions (0 to 5). Each 
observation lasted for 900s (3 x 300s). An average pain index was calculated to reflect 
the intensity of pain. 
 
Fig. 4. The criteria used for quantification. Six possible positions of the operated hind paw are rated 
from 0 to 5 in order to quantify the pain behavior. Adapted from Attal et al 
77
. 
5.4.2 Mechanical stimulation 
The animals were placed on a metal mesh plate with 0.6x0.6cm cells. After the period 
of habituation, mechanical stimulation was applied to the plantar region of the 
operated paw with 6 calibrated von Frey filaments ranging from 0.6g to 15.0g (North 
coast medical, USA). The mechanical stimulation was performed when the paw was 
pressed on the floor. Stimulation was applied until the filament bent. At this moment, 
the fibers’ force was fully exerted. Every single trial contains 6 stimulations of 
filaments at a frequency of 1/s. The same procedure was repeated using each 
filament in an ascending order from 0.6g to 15.0g. Five trials were performed each 
time. An interval of 3min was allowed between each trial. The result was expressed as 
a withdrawal frequency towards each filament (paw withdrawals/5 * 100%=% 
withdrawal frequency) 78.  
5.5 Measurement of paw temperature 
Skin temperature of bilateral paws was measured on different days (day 0, 2, 4, 7, 14, 
21 and 28). Animals were anesthetized with isoflurane and a surface electrode (skin 
temperature probe 400TM, Covidien, USA) was placed on the plantar region of the 
paw (Fig. 5A). The temperature of each paw was noted and the difference between 
                                                                                                                 Material and Methods 
26 
 
the operated side and the control side was calculated. The temperature difference 
was finally expressed as an absolute value, since the operated paw could become 
either abnormally warm or cold. 
5.6 Measurement of paw volume and edema 
The volumes of both paws were measured following the temperature measurement. 
The paws of both sides were immersed in a calibrated cylinder filled with water until 
the fluid level just reached the proximal tip of the glabrous surface of the heel 74 (Fig. 
5B). The volume difference between both sides was calculated (volume difference= 
operated side - control side) and served as a parameter of edema. In addition, edema 
in the traumatized muscle was assessed ex vivo. On the relevant final days of the 
experiment (day 2, 7 and 28), the animals were put to death and the tibialis anterior 
muscles of both sides were excised. The wet weight of the muscles was measured 
immediately. After that, the muscles were kept and dried in a laboratory oven (60°C) 
for 72 hours, the dry weight was then measured. A dry/wet weight ratio was 
calculated. A fraction of operated side to control side was later calculated with the 
formula below and served as an indice of muscular edema: 
Edema fraction = (dry/wet ratio of operated side) / (dry/wet ratio of control side). 
  
Fig. 5. Measurement of temperature (A) and volume (B). A: Two surface electrodes were placed onto 
the plantar region of the paws in order to measure the temperature; B: The paw of an anesthetized rat 
was immersed in a calibrated cylinder filled with water to measure the volume. 
 
5.7 Nerve conduction study 
Nerve conduction was performed on the final experimental day (day 2, 7 and 28) to 
assess the conductive function of the sciatic nerve. Pentobarbital-anesthetized 
animals were placed on a warm plate to maintain the body temperature (37°C). The 
sciatic nerve of the operated side was carefully exposed and freed from the 
A B 
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surrounding tissue. For the nerve conduction, a ground electrode was placed in the 
subcutaneous tissue between stimulating and recording site 79. Two recording needle 
electrodes were positioned in the tibialis anterior muscle and the flexor muscle in the 
paw. Electrical stimulation was performed in the operated sciatic nerve by a 
stimulator (A320, World Precision Instruments, Berlin, Germany) (Fig. 6). The 
stimulations (0.2V, 300ms) were applied to both the proximal and the distal trunk of 
the injured site. The conduction curves were recorded and analyzed off line with the 
program LabVIEW (National Instruments, USA). To analyze the conductive curve, the 
starting point of descending branch of the curve was marked. The conductive time 
(ms) from zero (the starting point of the motor evoked potential) to the beginning of 
descending branch was calculated by program. After that, the conductive latency 
between the proximal and distal site was calculated with the following formula: 
Conductive latency (ms) =conductive time (proximal) - conductive time (distal). 
The conductive latency of sham group without nerve injury served as baseline. 
  
Fig. 6. Nerve conduction study. A: The left sciatic nerve (*) was exposed, the electrodes were placed in 
respective positions. 1: the positive pole of the stimulator; 2: the negative pole of the stimulator; 3: the 
ground electrode; 4: the recording electrode in the tibialis anterior muscle; 5: the recording electrode 
in the muscle of the paw; B: The starting point of the descending branch (white arrow) was marked on 
the curve in order to calculate the conductive time. 
5.8 In vivo high resolution fluorescence microscopy 
In vivo high resolution fluorescence microscopy was performed in the traumatized 
soleus muscle on the final days of the experiment (day 2, 7 and 28). After the 
assessment of nerve conduction, subsequent surgery was performed. A cervical 
median approach was made through skin and the platysma, the skin and the platysma 
were pulled to both sides in order to expose the trachea and the carotid arteries 
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which ascend along the side of the trachea. The trachea was intubated and connected 
to a mini ventilator (TSE-994500, Technical & Scientific Equipment, Germany). 
Mechanical ventilation was applied (room air, 0.8ml/100g body weight; 17 
breaths/min). The right carotid artery was carefully freed from the carotid sheath and 
further separated from the vagus and the sympathetic nerve. The distal side of the 
carotid artery was ligated. A tiny transverse incision was made proximally to the 
ligature. A catheter (PE-50; Portex, Hythe, Kent, UK) was placed into the carotid artery. 
The catheter was fixed for later administration of fluorescent dyes and continuous 
monitoring of central hemodynamics (Sirecust; Siemens, Germany).  
The traumatized soleus muscle was surgically prepared for the in vivo fluorescence 
microscopy. The affected hindlimb was fixed and a longitudinal incision was made in 
the skin and subcutaneous fascia in the tibial anterolateral region. The fascia was 
retracted posteriorly in order to expose the soleus muscle. The soleus muscle was 
stretched moderately to allow sufficient surface for scanning. After a plane surface 
was prepared, a piece of cover glass was placed on the muscle and the space between 
the cover glass and the muscle was filled with 37°C warm physiological saline to 
prevent the muscle from drying. The plane surface of the muscle had to be as 
horizontal as possible to give convenient access for the following microscopic 
examination (Fig. 7A). The animals were allowed to recover from the surgery for 30 
min. During this period, the animals were adjusted to physiological hemodynamic and 
ventilation parameters (mean arterial blood pressure 100–120mmHg; pO2 70-
90mmHg; pCO2 30–40mmHg; pH 7.35–7.45). 
For in vivo microscopic examination, a high resolution fluorescence microscope (B46-
0013d, Zeiss, Germany) equipped with a blue filter (excitation/emission 465-
495nm/>505nm), a green filter (510-560nm/>575nm) and an ultraviolet filter (UV 
filter) (340-380nm/>400nm) was used in the experiment. During the fluorescence 
microscopy, the whole surface of the soleus muscle was scanned and microscopic 
images of 5 different sites were chosen for assessment. Before administration of 
fluorescent dyes, NADH autofluorescence was measured by exposition to ultraviolet 
epi-illumination for 10s and observation with the UV filter (40x). 
Fluoresceinisothiocyanate (FITC)-labeled dextran (15mg/kg body weight, Sigma, 
Germany) and Rhodamine 6G (0.15mg/kg body weight, Sigma, Germany) were 
injected intra-arterially to enhance the contrast of the microvascular network and 
stain the leukocytes in vivo 38. The capillaries were observed under the blue filter 
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(40x). Subsequently, 5 flowing venules were identified under the blue filter (20x). 
Leukocyte movement was observed in the same venules with the green filter (20x). 
The optical source was shaded with a shutter during the intervals of observation in 
order to avoid phototoxic effects. Microscopic images were captured with a charge-
coupled device video camera (FK-CM-2412-2-01-IQ-R4, Pieper, Germany) and 
recorded onto an S-VHS video system for subsequent offline analysis.  
  
Fig. 7. In vivo fluorescence microscopy. A: The traumatized Soleus muscle (white arrow) was prepared 
for microscopic examination; B: The soleus muscle (black arrow) was scanned with a fluorescence 
microscope. 
5.9 Microcirculatory analysis 
The microscopic images recorded on video tapes were analyzed offline using a micro-
circulation image analysis program (CapImage, Zeintl, Heidelberg, Germany). To 
assess the NADH autofluorescence, the image frame on the 10th second was taken 
for analysis. The program-assisted gray level determination was performed on the 
inter-capillary tissue in order to avoid the interference of the microvascular structures.  
The functional capillary density (FCD) was defined as the overall length of perfused 
capillaries in each observation field. The functional capillaries in the dynamic images 
were marked manually, the whole length of the capillaries and the total area of 
observation field were calculated by the program Capimage. The value of FCD was 
given as “cm/cm2” (overall length/total area). 
The leukocyte-endothelial interaction was assessed by recording the dynamic images 
of post-capillary venules for 30s. Based on the behavior, leukocytes inside post-
capillary venules were divided into 3 types which include floating leukocyte (passes 
quickly with the blood flow), rolling leukocyte (rolls along the vessel wall and the 
velocity is below 40% of normal) and adhering leukocyte (adheres firmly to the vessel 
wall without moving). Leukocytes were counted according to the different behavior. 
A B 
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Rolling leukocytes was expressed as a percentage ((rolling cell) / (rolling cell + floating 
cell) %). Diameter and length of the analyzed venule section were also measured to 
calculate the area of the endothelial surface (mm2), assuming cylindrical micro-vessel 
geometry. The leukocyte adherence was expressed as nonmoving leukocytes per 
endothelial surface (sticking cell / area of endothelial surface) (n/mm2) 74. For the 
analysis of vascular permeability, a program-assisted grey level determination was 
performed on both intra-vascular area and the tissue surrounding area. The 
parameter of vascular permeability was expressed as a “leakage fraction” (extra-
vascular grey level / intra-vascular grey level) which reflects the extent of vascular 
permeability.  
For analysis of NADH autofluorescence, the functional capillary density (FCD), 
leukocyte rolling, leukocyte adherence and the vascular permeability, 5 observation 
fields were analyzed for each parameter and the results were finally given as a mean 
value.  
5.10 Assessment of muscle cell apoptosis 
In vivo apoptotic cell death was observed under the fluorescence microscope. 
Staining of myocyte nuclei was performed by intra-arterial injection of bisbenzimide 
(Hoechst 33342; 10mmol/kg) 74. The bisbenzimide marked cells were identified under 
the UV filter (40x). The apoptotic cells i.e. those showing typical signs of apoptosis 
such as nuclear condensation and fragmentation, were counted and expressed as 
“n/observation field”. 10 observation fields were taken for assessment, the result is 
given as a mean value. 
The muscle cell apoptosis was further assessed ex vivo. After fluorescence microscopy, 
animals were put to death and the traumatized soleus muscle was excised and fixed 
with 4% formalin. Paraffin sections of muscular tissue were prepared for 
immunostaining. To assess the cell apoptosis, cleaved caspase-3 staining was 
performed with a rabbit anti-cleaved caspase-3 antibody (1:400, No.9661, cell 
Signaling Technology, Frankfurt, Germany). The sections were analyzed under a light 
microscope (BX 51, Olympus, Japan) (400x). The caspase-3 positive cells were counted. 
The area of each observation field is 1 mm2 and the result was expressed as n/mm2. 
25 different observation fields were analyzed, the result was finally given as a mean 
value. 
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5.11 Baseline setting 
For the assessment of pain behaviors, temperature and volume asymmetry, the 
intragroup values of day 0 were taken as baseline. In vivo fluorescence microscopy 
and immunohistochemistry were performed in another 6 healthy animals. The results 
of the healthy animals served as baseline for ex vivo assessment of muscular edema, 
regional inflammation, microcirculation and muscle cell apoptosis. 
5.12 Statistical analysis 
Statistical evaluation was performed with SigmaStat (Sigmastat; Jandel Scientific, San 
Rafael, CA, USA). Based on the normality and equal variance across groups, data was 
evaluated with analysis of variance (ANOVA), followed by Holm-Sidak test. Results are 
given as mean ± Standard Error of the Mean (SEM) and statistical difference was set 
at P<0.05. 
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6 Results 
In general, the experimental animals were well kept and had gradually gained weight 
during the study (Tab. 3). No behavior of autotomy was observed. No animal was 
ruled out due to infection or other diseases. 
Tab. 3. The weight gain of animals within 28 days 
 day 0 day 2 day 4 day 7 day 14 day 21 day 28 
sham 273±6 g 282±7 g 293±7 g 312±9 g 369±5 g 409±5 g 435±5 g 
clamp 281±4 g 291±6 g 302±6 g 316±6 g 361±9 g 395±10 g 421±11 g 
* n=7 for each group, data are given as mean ± SEM. 
6.1 Neuropathic pain 
In order to assess the pain, the method of behavior observation was carried out. 
Based on the different positions which were presented in the affected paws, the pain 
was rated and quantified.  
On day 0 prior surgery, spontaneous pain or nociceptive responses to hot and cold 
was absent in all the animals. During the test of mechanical stimulation, animals 
showed slight withdrawal reactions to von Frey filaments ranging from 6.0g to 15.0g, 
but rarely responded to forces from 0.6g to 2.0g.  
Shortly after the surgery up to day 7, pronounced signs of neuropathic pain were 
observed in the clamp group. These signs include spontaneous pain, hot and cold 
allodynia and mechanical hyperalgesia. Spontaneous pain and allodynia decreased 
over day 14 and 21 and completely vanished within 4 weeks. Mechanical hyperalgesia 
was also found to be alleviated, but it did not disappear within 28 days. In the sham 
group with sole soft tissue trauma pain did not develop. 
6.1.1 Spontaneous pain 
Spontaneous pain is the pain behavior expressed under room temperature (25˚C) 
without further stimulation. On day 2, the affected paws of the clamp group 
commonly showed position 1 or position 2, which reflect a spontaneous pain. As 
shown in Fig. 8B, the index of spontaneous pain was found to be elevated on day 2, 
peaked between day 4 and day 7. The pain index went back to baseline on day 21 
representing the paw placed normally on the floor. 
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6.1.2 Hot and cold allodynia 
On day 2, the animals of the clamp group demonstrated pronounced responses to hot 
and cold simulations. They behaved restlessly during the observation, which produced 
a stark contrast with the calm behavior of the sham group. Besides position 1 and 2, 
positions indicating high pain intensities such as position 4 (elevating the paw) and 
position 5 (licking the paw) were also observed. As shown in the graphs (Fig. 8C and 
D), the pain indices of the hot and cold allodynia were elevated on day 2 and reached 
the peak between day 4 and day 7 being parallel with the spontaneous pain. However, 
hot and cold allodynia lasted until day 21 and went back to baseline on day 28.  
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Fig. 8. Assessment of neuropathic pain. A: An animal from the clamp group showed position 1 in the 
operated limb; B: Index of spontaneous pain; C: Index of hot allodynia; D: Index of cold allodynia. Values 
are given as mean ± SEM; Two Way ANOVA followed by Holm-Sidak Test, * P<0.05 vs sham group, # 
P<0.05 vs day 0. 
6.1.3 Mechanical hyperalgesia 
Mechanical stimulation was applied with 6 calibrated von Frey filaments ranging from 
0.6g to 15.0g. The animals of the clamp group showed a heightened response to the 
mechanical stimulation, especially to higher masses (6.0g, 10.0g and 15.0g). Since the 
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C 40˚C D 4˚C 
 
A 
                                                                                                                                             Results 
34 
 
stimulations rated from 6.0g to 15.0g were also able to evoke withdrawal responses 
in healthy animals, the relatively enhanced reaction after surgery was interpreted as 
mechanical hyperalgesia. The mechanical hyperalgesia appeared along with other 
signs of pain. As shown in Fig. 9, the withdrawal frequency of the clamp group was 
found to be elevated on day 2 and most pronounced between day 4 and day 7. After 
day 7, it began to decline. This trend of decline continued until the final day of 
experiment. On day 28, compared with the readings in the first week, the mechanical 
hyperalgesia of the clamp group was found to be still alleviated and showed 
significant difference to that of the sham group. Compared with other signs of 
neuropathic pain, the mechanical hyperalgesia seems to be more long-lasting. In 
addition, the withdrawal responses to lower forces (0.6g to 2.0g) were also enhanced 
in the clamp group. A significantly heightened reading (2.0g) was detected on day 7, 
which can be interpreted as a sign of mechanical allodynia. This significant reading 
disappeared at day 14. 
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Fig. 9. Assessment of mechanical hyperalgesia. Withdrawal 
frequency (%) of the hindlimb evoked with von Frey filaments. 
Values are given as mean ± SEM; Two Way ANOVA followed by 
Holm-Sidak Test, * P<0.05 vs sham group, # P<0.05 vs day 0. 
 
6.2 Nerve conduction study  
The conduction curve and latency of the sham group was altered over 28 days and 
served as baseline (mean ± SEM=0.09 ± 0.03ms). After the surgery in animals of the 
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clamp group, the electromyography showed abnormal curves on day 2 and day 7 and 
the assessment of latency measurement was not possible. This condition was found 
improved on day 28, approximately normal curves were commonly detected in the 
clamp group. Compared with the baseline, a significantly prolonged latency could be 
assessed in the clamp group (mean ± SEM=0.25 ± 0.08ms) (Fig. 10).  
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Fig. 10. Results of electromyography. A: 
Conduction curve of the sham group 
(proximal); B, C, D: Conduction curves of the 
clamp group on day 2, 7 and 28 (proximal); 
E: Assessment of the conductive latency 
(ms) of both groups on day 28. Values are 
given as mean ± SEM; One Way ANOVA 
followed by Holm-Sidak Test,* P<0.05 vs 
sham group. 
 
6.3 Paw temperature asymmetry 
The temperature differences between the operated paw and the control side were 
calculated on different days. According to the value at day 0, there is a natural 
temperature asymmetry between the paws of both sides. The natural difference is 
less than 0.4˚C. After surgery, both groups showed temporally enhanced temperature 
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asymmetries. The temperature difference was finally expressed as absolute value, 
because the operated paw may become either warmer or colder after surgery, but in 
our study, the operated paw was always warmer than the control side (0.83˚C-0.90˚C). 
As shown in Fig. 11A, the enhanced temperature asymmetries in both groups 
appeared on day 2 and day 4 and went back to baseline on day 7. The clamp group 
showed no difference compared with the sham group. 
6.4 Assessment of edema 
The volumes of both paws were measured and differences between both sides were 
calculated subsequently. There was a volume increase in both groups on day 2, which 
indicates edema formations in the traumatized muscle. The muscular edema of both 
groups was transient since the readings went back to baseline on day 7. No 
intergroup difference appeared (Fig. 11B).  
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Fig. 11. A: Assessment of temperature asymmetry (˚C). Values are given as mean ± SEM; Two Way 
ANOVA followed by Holm-Sidak Test. # P<0.05 vs day 0; B: Assessment of intramuscular edema 
fraction. Values are given as mean ± SEM; One Way ANOVA followed by Holm-Sidak Test, # P<0.05 vs 
baseline. 
6.5 Assessment of microcirculation 
Signs of microcirculatory deterioration and regional inflammation in the traumatized 
soleus muscle were observed by in vivo fluorescence microscopy and analyzed offline. 
After the surgery, both the sham and clamp group developed regional inflammatory 
responses, tissue perfusion failure and sign of hypoxia on day 2. However, the 
inflammation and signs of microcirculatory deterioration were almost absent in both 
groups on day 7. No evidence of persistent inflammation was found. 
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6.5.1 Tissue perfusion failure and signs of tissue hypoxia 
NADH is an entry enzyme of oxidative phosphorylation in the mitochondria. Elevated 
levels of NADH can be interpreted as signs of tissue hypoxia 80. As shown in Fig. 12, a 
heightened autofluorescence of NADH was observed in both groups under epi-
illumination on day 2, which reflected tissue hypoxia after surgery. The NADH 
autofluorescence of both groups went back to baseline at day 7 and day 28. 
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Fig. 12. Assessment of NADH autofluorescence. A: A heightened autofluorescence of NADH was 
observed on day 2; B: The NADH autofluorescence returned to baseline on day 7; C: Index of NADH 
autofluorescence (arbitrary unit (aU)). Values are given as mean ± SEM; One Way ANOVA followed by 
Holm-Sidak Test, # P<0.05 vs baseline.  
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Fig. 13. Assessment of functional capillary density (FCD). A: Thrombosis in a capillary on day 2 (black 
arrow); B: Elevated FCD on day 28; C: Quantitative anlysis of the FCD (cm/cm
2
). Values are given as 
mean ± SEM; One Way ANOVA followed by Holm-Sidak Test, # P<0.05 vs baseline.  
The functional capillary density (FCD) represents the number of regional nutritive 
capillaries and reflects the condition of tissue perfusion. FCD was found lowered in 
both groups on day 2 and day 7 when compare to the baseline values. Besides the 
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decreased number in capillaries, thrombosis was also observed in some microvessels 
(Fig. 13). FCD was finally detected to reach baseline values of approximately 600 
cm/cm2 on day 28. There were no statistical significant differences of the NADH 
autofluorescence and the FCD between the sham and clamp group. 
Regression analysis showed an inverse correlation between FCD and the NADH 
autofluorescence in both groups i.e. the higher the FCD is, the lower the NADH 
autofluorescence is (Fig. 14). This result indicates that the extent of tissue hypoxia is 
closely related to FCD which reflects the tissue perfusion. 
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Fig. 14. Linear regression analysis between FCD and NADH autofluorescence over 28 days. A: 
Regression analysis in sham group; B: Regression analysis in clamp group. R= regression coefficient.  
6.5.2 Regional inflammation 
Pronounced signs of regional inflammation in the skeletal muscle were observed in 
both groups on day 2. These signs include enhanced interaction between leukocytes 
and vascular endothelium as well as increased vascular permeability.  
The enhanced interaction between leukocytes and vascular endothelium was 
reflected by an increased fraction of rolling leukocytes (leukocytes which moved 
along the vessel wall at a velocity less than 40% of normal) and number of adhering 
leukocytes (leukocytes which adhered firmly to the endothelium without moving). 
This enhanced interaction was commonly observed even in fast flowing vessels (Fig. 
15). Increased vascular permeability developed along with the enhanced leukocyte-
endothelial interaction. Under normal conditions, the fluorescent dye is restricted 
inside the vessels due to its high molecular size. When the vascular permeability 
increases, the macromolecular dye can leak into the surrounding tissue. As we can 
see from Fig. 16, the enhanced leakage of fluorescent dye was observed in both 
A B 
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groups on day 2 which indicated an increased vascular permeability. The vascular 
permeability of both groups recovered on day 7. 
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Fig. 15. Assessment of leukocyte-endothelial interaction. A, B, C: Representative images of enhanced 
leukocyte-endothelial interaction. Beside adhering leukocytes (A, B: black arrow), a rolling leukocyte 
was moving in a low velocity (A, B: white arrow) (a time gap of 3s between A and B); Increased 
adhering leukocytes were observed on day 2 (C: white arrows); D: Leukocyte rolling fraction (%); E: 
Leukocyte adherence (n/mm
2
). Values are given as mean ± SEM; One Way ANOVA followed by Holm-
Sidak Test, # P<0.05 vs baseline. 
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Fig. 16. Assessment of vascular leakage. A: The fluorescent dye leaked into the surrounding tissue due 
to increased vascular permeability (black arrow); B: The vascular permeability was restored on day 7 
(white arrow); C: Vascular leakage fraction. Values are given as mean ± SEM; One Way ANOVA followed 
by Holm-Sidak Test, # P<0.05 vs baseline. 
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As shown in Fig. 15 and Fig. 16, the signs of regional inflammation were observed in 
both groups on day 2 and disappeared on day 7. The clamp group showed no 
statistical significant difference to the sham group. No evidence of persisting 
inflammation was detected since all the inflammatory parameters went back to 
physiological values within 7 days. 
6.6 Muscle cell apoptosis 
Muscle cell apoptosis in the traumatized soleus muscle was assessed by both in vivo 
fluorescence microscopy and caspase-3 immunohistochemistry. Enhanced cell 
apoptosis in the traumatized muscle was detected in both groups. Under the 
fluorescence microscope apoptotic cells with nuclear condensation were observed. 
Quantification analysis showed a heightened number of cells with signs of apoptosis 
on day 2 and day 7 in both groups (Fig.17). This finding matched with the results of 
the caspase-3 cell staining (Fig.18). Caspase-3 positive cells were also observed under 
the light microscope in both groups on day 2 and day 7. This enhanced cell apoptosis 
was resolved within 28 days and almost absent in both groups. The apoptosis in the 
clamp group was slightly more pronounced than that of the sham group, however, no 
statistical significant difference was detected. 
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Fig.17. A: Assessment of cell apoptosis by in vivo fluorescence microscopy. A: Bisbenzimide marked 
myocytes with nuclear condensation were observed on day 2 (black arrow); B: Apoptotic cells were 
rarely found on day 28; C: Quantitative analysis of cell apoptosis. Values are given as mean ± SEM; One 
Way ANOVA followed by Holm-Sidak Test, # P<0.05 vs baseline. 
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Fig.18. Assessment of cell apoptosis by caspase-3 immunohistochemistry. A, B, C, D: Representative 
images of caspase-3 staining under light microscope. Increased caspase-3 positive cells (black arrows) 
were commonly observed within 7 days in both groups (A, B, C). Apoptotic cell death was absent on 
day 28 (D); E: Quantitative analysis of caspase-3 staining. Values are given as mean ± SEM; One Way 
ANOVA followed by Holm-Sidak Test, # P<0.05 vs baseline. 
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7 Discussion 
CRPS 1 is traditionally thought to be distinguishable from CRPS 2 by the absence of a 
definite nerve lesion. However, this current dogma of CRPS 1 has been challenged by 
a series of reports describing minimal nerve injury as a pathophysiologic important 
feature of CRPS 1 64.65. In our study, we combined a closed soft tissue trauma and a 
minimal nerve injury in order to establish a novel animal model for CRPS 1. A 
controlled closed soft tissue trauma was applied in the hindlimbs of rats, leading to an 
acute high-energy impact injury. In addition, the ipsilateral sciatic nerve which is the 
dominant nerve trunk of the hindlimb was slightly crushed with an instrumented 
clamp to cause a minimal nerve injury. In the pilot experiment, several settings (force, 
duration) of the crush injury were tested. The optimized parameters (30 Newton, 20s) 
were chosen in order to induce a recognizable nerve lesion. 
Sensory disturbance, especially pain, is usually the chief complaint of human CRPS. 
The patients can experience spontaneous pain, allodynia (to a light touch or 
temperature sensation) and hyperalgesia (to painful stimulation such as pinprick) 15, 81. 
In order to assess the pain, spontaneous behavior and nociceptive responses to 
different stimuli (hot, cold and mechanical stimulations) were observed and 
quantified. After the surgery, the minimal nerve injury initiated a quick onset of 
neuropathic pain in the clamp group. The animals developed pronounced signs of 
neuropathic pain, which included spontaneous pain, hot and cold allodynia and 
mechanical hyperalgesia. Abnormal positions of the operated paw, which are 
interpreted as guarding behaviors, were commonly observed in the clamp group. 
Besides the aberrant postures, the animals with nerve lesion also behaved anxiously 
and restlessly, especially under the condition of hot (40˚C) and cold (4˚C), which were 
tolerable to the animals prior surgery. These findings mirror hot and cold allodynia in 
human, which stands for abnormal pain incited by innocuous stimuli. When applying 
the mechanical stimuli, the animals with the minimal nerve injury often ran around or 
elevated their paws to escape from the stimulation. Elevated withdrawal frequencies 
to mechanical stimuli ranging from 6.0g to 15.0g have been observed from day 2, 
which indicated mechanical hyperalgesia. The withdrawal responses to lower masses 
(0.6g, 1.4g and 2.0g) were also found to be enhanced after surgery, but only a 
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response to 2.0g reached statistical significance on day 7. However, this can be a 
transient sign of mechanical allodynia. 
 In contrast, the sham animals showed no sign of pain and behaved calmly during the 
observation. The single soft tissue trauma did not produce any symptoms of pain. In 
our animal model, the quick onset of neuropathic pain was dependent on the minimal 
nerve injury. 
Neuropathic pain appeared rapidly after the minimal nerve injury. One possible 
reason may be hyperexcitability of the peripheral nociceptors. Crush injury to the 
nerve usually leads to damage of axons and the severity of axonal damage is related 
to the intensity of the injury 82. We speculate that the minimal nerve injury led to a 
partial damage to the affected nerve, meaning that some of the axons were damaged 
during the surgery and others survived. It was found that partial nerve damage is 
more likely to induce neuropathic pain than whole nerve transection 40. The damaged 
fibers do not directly participate in pain generation. However, they may sensitize 
adjacent surviving fibers to generate more pain 83, 84. Wu and his colleagues 
performed ligation and transection of the L 5 spinal nerve in rats and caused 
neuropathic pain 83. Interestingly, spontaneous activity was also recorded in the 
uninjured L 4 spinal nerve. This spontaneous activity was proven to originate from 
peripheral nociceptors 83. In another study of Ali et al, a lesion was induced in the L 6 
spinal nerve, but spontaneous activity and adrenergic sensitivity were found in 
cutaneous C fibers which arose from the adjacent uninjured spinal nerves 84. These 
studies indicate that a nerve lesion can lead to changes in uninjured nerves and 
produce pain. After a nerve lesion, proinflammatory factor (TNF-α), neuropeptides 
(SP and CGRP) and nerve growth factor (NGF) are secreted by the peripheral 
nociceptors and Schwann cells of the injured nerve fibers 39, 58, 83. Since the injured 
and uninjured nerve fibers coexist in the clamped sciatic nerve, the adjacent surviving 
neighbors are exposed to the factors released from injured axons. This may be a 
reason why the sensory disturbance can spread in CRPS related pain symptoms. 
TNF-α is released by Schwann cells after a nerve lesion 85, 86 and is proven to play an 
important role in neuropathic pain 87, 88. Local application of TNF-α can induce hot 
hyperalgesia and mechanical allodynia 89-91. Sommer et al found that the hot 
hyperalgesia following a chronic nerve injury can be attenuated by a TNF-α inhibitor 92. 
TNF-α induced pain can be a direct effect on the primary afferent neurons. TNF 
receptor-1 and 2 (TNFR-1 and TNFR-2) are expressed in both the dorsal root ganglion 
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(DRG) and peripheral nociceptors. They are found to be up-regulated following a 
nerve injury 93-95. TNF-α activates its receptors in the peripheral nociceptors and leads 
to a decreased threshold to innocuous stimuli, enhanced response to noxious input 
and spontaneous activity 93,96. Besides the direct effect to the primary afferent 
neurons, TNF-α also has suppressive effects on myelin formation and may impair the 
nervous conduction 97. As a proinflammatory factor, TNF-α initiates a cascade of 
inflammatory factors (IL-1, IL-6 and IL-8). Those factors can induce warmth, redness 
and edema which are commonly observed in both inflammation and CRPS 89, 98.  
SP and CGRP may sensitize the peripheral nociceptor and produce mechanical 
allodynia via IL-1 β signaling 99. Besides the neuropeptides, NGF may also play a role in 
the development of pain since anti-NGF treatment was found to attenuate the pain 
behavior in the tibial fracture model 100. After the Schwann cells, another source of 
NGF in the affected region is the keratinocyte. It was found that SP stimulates the 
neurokinin-1 (NK-1) receptor expressed on keratinocyes and mediates an up-
regulation of NGF and TNF-α 101. A peripheral axon injury can also lead to changes in 
the affiliated cell body in the DRG and the neurons in the dorsal horn 58, 83, 102. 
Neuropeptides (SP, CGRP) and their receptor proteins were also up-regulated 
centrally in the dorsal horn following a peripheral nerve injury 42, 83. The peripherally 
released neuropeptides (SP, CGRP) and NGF can be taken up and transported to the 
central neurons by afferent nerve fibers (mainly C fibers) 83, 103. SP can activate the 
neurokinin-1 G-protein–coupled receptor in the dorsal horn and lead to a long lasting 
membrane depolarization 104, 105. CGRP participates in the development of central 
sensitization by activating the postsynaptic CGRP-1 receptor 106. The expression of the 
CGRP-1 receptor proteins can be enhanced by NGF 13. This complicated network 
suggests a synergy effect of different factors. 
Except the different factors released after nerve lesion, myelin damage and 
remodeling can be another reason of neuropathic pain. Clamping injury can damage 
the myelin sheath of small myelinated fibers (Aδ-fibers) 82. The myelin sheath is 
essential for maintaining a stable velocity of conduction and preventing the 
interferences between different axons. Damage to the myelin is often the cause of 
sensory disorders. Demyelination is the main pathological change of multiple sclerosis, 
Guillain-Barre syndrome and diabetic neuropathy which are also characterized by 
neuropathic pain and sensory disturbance 107. Zhu et al reported that neuropathic 
pain developed immediately after cobra venom induced demyelination in a sciatic 
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nerve if rat 108. In this study, besides the conductive impairment of A-fibers, the 
unmyelinated C fibers were also affected. Spontaneous antidromic activity and hyper-
excitability of C-fiber polymodal nociceptors were detected following demyelination. 
The antidromic activity of C fibers was reduced by stimulating the A-fibers in the 
ipsilateral sciatic nerve and appeared again when stopping the stimulation 108. This 
may suggest that the normal activity of myelinated A-fibers can inhibit the ectopic 
activity of C-fibers. It was proposed that the GABAergic and glycinergic inhibitory 
neurons in the dorsal horn, which were activated by the input of A-fibers, are 
responsible for maintaining normal sensory signaling 109, 110. Activation of inhibitory 
interneurons can depress the central terminals of C-fibers and prevent the antidromic 
activity and consequent hyperexcitability of peripheral nociceptors 108.  
As in our animal model, the impaired nerve conduction of the sciatic nerve was 
proven by electromyography, which can be an evidence of myelin damage. An 
impaired input of A-fibers might lead to dysfunction of the central inhibitory 
interneuron and hyper-excitability of peripheral nociceptors of C-fibers. The surviving 
nociceptors might also be sensitized by the factors which were released after partial 
nerve damage. Those changes would lead to pronounced symptoms of neuropathic 
pain which appeared rapidly after nerve clamping. As we can see from the present 
results, the ratings of spontaneous pain and allodynia were found elevated on day 2, 
peaked between day 4 and day 7. Then the ratings of pain began to decline towards 
zero. As a result, the spontaneous pain and allodynia vanished on day 28. The upward 
curve represented the progressive onset of neuropathic pain while the downward 
curve could be interpreted as a process of recovery.  
Haftek and colleagues examined the microstructure of clamped nerves by electron 
microscopy in 1968. He found that, besides the damage of axons and myelin, the 
integrity of the endoneurial tubes and Schwann cell basal lamina altered 82. In our 
study, we clamped the sciatic nerve slightly in order to induce a minor injury. So we 
postulate that the integrity of the endoneurial tubes and Schwann cell basal lamina of 
the clamped nerve were still intact. Intact membrane tubes offer a good environment 
for regeneration, since the broken axons were still in their parent tubes. The 
endoneurial tubes can guide the regenerating axons towards their appropriate targets. 
Remyelination can also be well supported by the intact Schwann cell basal lamina 111. 
As a result, the process of nerve regeneration can be faster and more accurate after a 
minimal nerve injury. The nerve begins to regenerate in a few hours after the lesion. 
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The regenerating axons sprout from the proximal side of the injured nerve and grow 
into the endoneurial tubes 111. Those newborn sprouts fire easily and can develop 
spontaneous activity, which may lead to pain 83, as seen in the present study.  
At the same time, the distal segment of the injured nerve began the regeneration by 
Wallerian degeneration. Wallerian degeneration is an essential part of the nerve 
regeneration 111. It happens after a nerve injury and begins in the distal stump of the 
injured axons, usually 24-36 hours after injury 112. The Wallerian degeneration 
includes three stages, which are axon and myelin degeneration, debris clearance and 
regeneration 113. The axons and myelin in the distal stump degenerate soon after the 
nerve injury. Schwann cells and macrophages are activated and begin to phagocytize 
the myelin fragments and axonal debris. Of note, several inflammatory factors (IL-1, 
IL-6, TNF-α), cytokine (GM-CSF) and nerve growth factor (NGF) are released by the 
activated Schwann cell 114. TNF-α can sensitize the peripheral nociceptors, as 
mentioned above. The neuropeptides may affect the nociceptive afference via IL-1 β 
signaling 99. Those factors might play an important role in the development of 
neuropathic pain, since they can affect the surviving fibers which are mixed with the 
degenerating nerve fibers. In a study of La Fleur M et al, the level of TNF-α was found 
to increase progressively and peak on day 7 distal to a crushed nerve 115. An earlier 
peak was showed in the study of Rotshenker et al, they reported a peak of TNF-α and 
IL-1β on day 2 after nerve lesion 114. As in our model, the pain ratings of spontaneous 
pain and allodynia were found elevated on day 2 and peaked between day 4 and day 
7. The burst of neuropathic pain in the first week after nerve lesion can be closely 
related to the production of several factors during Wallerian degeneration. The 
neuropathic pain was found to be alleviated on day 14 and vanished after 28 days, 
which can be a consequence of a down-regulation of pain-inducing factors. 
The quick production of pain-inducing factors is followed by a secretion of anti-
inflammatory factors such as IL-10. IL-10 is mainly produced by the subsequently 
recruited macrophages. IL-10 gradually down-regulates the inflammatory factors, 
finally bring the cytokine secretion in Wallerian degeneration to a conclusion in 2 or 3 
weeks 114. This down-regulation of pain-inducing factors may be reflected by the 
downward curves of neuropathic pain in the present study. 
After the stage of debris clearance, the regeneration begins. Schwann cells line up in 
the endoneurial tubes and synthesize NGF, which attracts axonal sprouts from the 
proximal segment of the injured nerve 114, 116. Remyelination happens at the same 
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time. Schwann cells form a line termed Bands of Bungner within the endoneurial tube, 
guiding the production of new formed myelin 117. The remyelinated fibers regain their 
function gradually along with the remyelination. As described above, the activity of 
myelinated A-fibers may activate the interneurons in the dorsal horn and regulate the 
nociceptive afference. The regained activity of A-fibers can depress the hyper-excited 
polymodal nociceptors. As a result, the remyelination is parallel with the relief of pain.  
As we can see from our study, the gradually recovered nerve conduction is reflected 
by the electromyography. Following the anomalous readings on day 2 and day 7, the 
clamp group showed approximately normal curves on day 28, but with a prolonged 
latency. The regenerated myelin is thinner than normal and the internodes between 
the newly formed Ranvier nodes are also shorter, which can explain the slowed 
velocity and prolonged latency 118. 
Besides the spontaneous pain and allodynia, a mechanical hyperalgesia was also 
detected in the clamp group. Several studies suggest that, mechanical hyperalgesia is 
due to changes of the central nervous system 42, 119, 120. One possible mechanism of 
hyperalgesia is a activity dependent central sensitization, which stands for central 
sensitivity induced by repeated noxious stimulations 42. In a study, Wall and 
colleagues applied a brief low frequency electrical stimulation to the afferent C-fiber 
for 20s and induced pain hypersensitivity for up to 90min 42. In another study of 
Hathway et al, the electrical stimulation for 5min led to a mechanical hypersensitivity 
for 48 hours 121. This hypersensitivity may be induced through activation of TRPA1 and 
TRPV1 channels in the dorsal horn neurons 122, 123. When applying mechanical 
stimulation in our study, an interesting phenomenon was observed. The first trial of 
stimulation usually did not induce many withdrawal responses. The withdrawal 
frequency began to increase with the second or the third trial. The first trial of 
repeated mechanical stimulation might serve as an induction of mechanical 
hypersensitivity under the condition of nerve lesion.  
Of note, compared with other signs of neuropathic pain, the mechanical hyperalgesia 
was more durable. After day 7, a trend of alleviation was detected in the mechanical 
hyperalgeisa as we could find that the response frequency of clamp group had greatly 
decreased on day 28. However, the response frequency of the clamp group was still 
significantly higher than that of the sham group on the final day of experiment, which 
reflects a prolonged mechanical hyperalgesia. This result is in accordance with the 
findings of Rotter et al. In this study, spontaneous pain, hot and cold allodynia and 
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mechanical hyperalgesia also developed after a sciatic nerve crush injury (25 Newton, 
30s). Rotter and colleagues performed observations for a longer period of 42 days. 
The animals with nerve injury were still showing a mechanical hyperalgesia on day 42 
when other signs of pain had already disappeared 127. These findings suggest that 
hyperalgesia may be the most persistent type of neuropathic pain, which develops 
after a nerve lesion.  
Besides the neuropathic pain, human CRPS also presents autonomic changes, such as 
red and glossy skin, altered temperature and edema 15. Some of these symptoms are 
similar to inflammatory responses. As it was already mentioned above, neuropeptides 
(SP, CGRP) are released by peripheral nociceptors following a nerve lesion 58. The 
neuropeptides may lead to changes as plasma extravasation and vasodilation as well 
as to warmth, redness and swelling 103. Based on this, some researchers proposed a 
neurogenic inflammation in CRPS 44.  
In the present study, the alterations of temperature and volume in the paws were 
assessed. Subsequently, we performed in vivo high resolution fluorescence 
microscopy in order to check the inflammatory response and perfusion failure in the 
traumatized muscle. As a result, we found an inflammatory response, local perfusion 
failure and temperature asymmetries in the clamp group. However, these symptoms 
comparably appeared in the sham group. This may suggest that these changes are 
results of a posttraumatic inflammation following the blunt muscle trauma rather 
than a neurogenic inflammation. 
On day 2, signs of muscular inflammation and local perfusion failure were observed in 
both groups. The high-energy soft tissue trauma led to an acute damage to the small 
vessels and capillaries in the traumatized area and contributed to a regional 
inflammation with increased vascular permeability and plasma leakage as well as 
enhanced leukocyte-endothelial interaction) 124. Capillary damage and posttraumatic 
muscular edema contributed to decreased FCD and further impairment of tissue 
oxygen exchange, which was reflected by an elevated level of NADH autofluorescence. 
The rapidly developed regional inflammation and microvascular deterioration were 
almost absent on day 7. The temperature asymmetries were heightened in both 
groups on day 2 and day 4. The operated side was warmer than the contralateral side. 
This can be explained by an inflammatory vasodilation. The temperature asymmetries 
also resolved on day 7 along with the local inflammation. Besides the temperature 
asymmetry, no volume change was detected in the remote paws and the edema was 
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restricted to the traumatized muscle. All the signs of inflammation and autonomic 
changes were alleviated within 7 days, but the neuropathic pain in the clamp group 
was still ongoing. In summary, this finding does not support a neurogenic 
inflammation being the reason of neuropathic pain in the present study. 
The enhanced apoptosis in both groups was confirmed by both fluorescence 
microscopy and caspase-3 immunohistochemistry. This enhanced apoptosis can be a 
result of direct cell injury by the closed tissue trauma 74. The subsequently released 
TNF-α also has a weak apoptosis inducing effect and it might particularly promote the 
apoptosis in the acute phase of regional inflammation 71. Interestingly, there was no 
difference detected between the clamp and the sham group, though a nerve injury is 
usually a reason for apoptosis in the innervated muscle 125, 126. In another study of 
Rotter et al, crush injuries were applied to both the soleus muscle and the ipsilateral 
sciatic nerve of rats. They found that compared with the groups with single muscle 
injury, muscle cell apoptosis was enhanced in the animals with both muscle and nerve 
injuries on day 1 and day 7 127. As in our study, the muscle cells apoptosis in the clamp 
group was also found to be more pronounced on day 2 and day 7, but no statistical 
significant difference was detected. The reduction of apoptosis in both groups within 
the consequent 28 days may reflect the process of recovery from tissue trauma in 28 
days.  
Our animal model successfully induced neuropathic pain which is the most important 
symptom of clinical CRPS. It is reasonable to state that a nerve lesion, even a minimal 
nerve injury, is sufficient to induce neuropathic pain for several weeks. This finding 
confirms the close relationship between nerve lesion and neuropathic pain. 
Compared with the needlestick distal nerve injury model (DNI), the current method 
mimics the trauma situation in humans better. However, as in our study, animals with 
minimal nerve injury presented all the phenotypes of pain. Additionally, the course of 
pain showed a high consistency. All the animals of the clamp group developed 
neuropathic pain on day 2 and recovered from most of the pain symptoms on day 28. 
This high reproducibility may let the minimal nerve injury become a standard method 
for producing temporal neuropathic pain. However, it is not able to perfectly model 
the natural incidence and pain course of human CRPS, since only a fraction of people 
with trauma or nerve lesion would develop CRPS and the courses of pain are very 
different from case to case. This is also the problem which most of the animal models 
suffer from 69, 70, 73. Interestingly, this point was emphasized in the DNI model by 
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Oaklander et al. They used the term “prevalence” to describe the data since only a 
portion of the experimental animals with DNI developed neuropathic pain and other 
symptoms, which may better model a prevalence of human CRPS 72. 
On the other hand, the spontaneous pain, hot and cold allodynia in the present study 
disappeared in 28 days. The mechanical hyperalgesia lasted longer, but it also showed 
a trend of alleviation, which might be attribute to the process of nerve regeneration, 
as the mechanical hyperalgesia in the clamp group disappeared later. Actually, most 
of the human CRPS cases can also remit or recover spontaneously, but the pain in 
human CRPS usually persists longer, sometimes from months to years. In the DNI 
model, some animals with mechanical hyperalgesia have already recovered on day 14 
and only one rat developed cold sensitization 72. The mechanical hyperalgesia induced 
in the model of exaggerated soft tissue trauma (ETR) also lasted for only 14 days 
while hot and cold allodynia were absent 73. In our study, the minimal nerve injury 
was accompanied with several phenotypes of pain (spontaneous pain, hot and cold 
allodynia and mechanical hyperalgesia) for longer period, but it is still not able to 
induce ongoing pain. The results of electromyography reflected the conductive 
function of the injured nerve and also presented a process of recovery in 28 days. This 
trend of recovery proceeded along with the alleviation of neuropathic pain. This 
finding in the present study may provide an evidence to support the idea that myelin 
damage is of pathophysiological importance in the development of neuropathic pain. 
Besides the neuropathic pain, inflammatory responses, muscular edema and 
temperature changes were detected in the operated limbs. However, those changes 
were transient in nature, similarly to what Gradl et al found in the model of 
exaggerated soft tissue trauma (ETR) 73. These symptoms are more likely to represent 
posttraumatic sequelae induced by the closed soft tissue trauma instead of being 
neurogenic, since both groups with tissue trauma developed regional inflammation, 
muscular edema and altered temperature regardless the presence of nerve lesion. 
This is in agreement with the results of the ETR model 73, 74. Accordingly, the 
neurogenic edema and temperature alteration were also absent in the DNI model 72.  
Loss of epidermal neurites and small fiber degeneration were reported in the human 
CRPS 1 affected limbs 64, which indicated a connection between nerve lesion and 
CRPS 1, but the distinct mechanism how a minor nerve lesion leads to ongoing 
changes in CRPS 1 can still not be explained. The method of chronic nerve constriction 
injury (CCI) is capable to induce long-lasting neuropathic pain and trophic changes, 
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but it is more likely to cause a remarkable nerve lesion which is typical for CRPS 2. 
Questions of how a minor nerve lesion and which method of minor nerve injury can 
induce ongoing autonomic and trophic changes are still not clear. Of note, in the 
present study, the minimal nerve injury produced pain, while the closed soft tissue 
trauma was responsible for the regional inflammation, perfusion failure, autonomic 
changes and muscle cell apoptosis. In the clinic, most of the nerve lesions are 
accompanied by tissue trauma, so the features of human CRPS 1 are possibly due to a 
combined effect of minor nerve lesion and tissue trauma.  
In summary, this novel animal model of closed soft tissue trauma combined with a 
minimal nerve injury has successfully produced CRPS-like symptoms, such as 
neuropathic pain and trophic changes. However, the high prevalence and short term 
of the symptoms are still not able to fully model the development of human CRPS. 
Anyhow, we have established a framework of new animal model for CRPS, different 
settings and this method of nerve lesion can be applied for further studies. 
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